In FGF19+FGFR4+ HCC and FGF19−FGFR4− HCC groups, 39.4% and 23.1% of patients had vascular invasion or tumor satellite nodules, respectively. The gene discussed is FGFR4; the disease is hepatocellular carcinoma.